{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:54:12Z","timestamp":1793069652703,"version":"4.5.0"},"publisher-location":"Cham","reference-count":83,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319660943","type":"print"},{"value":"9783319660950","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-3-319-66095-0_8","type":"book-chapter","created":{"date-parts":[[2017,10,28]],"date-time":"2017-10-28T01:43:42Z","timestamp":1509155022000},"page":"167-184","source":"Crossref","is-referenced-by-count":14,"title":["Peptides and Drug Delivery"],"prefix":"10.1007","author":[{"given":"Kavisha R.","family":"Ulapane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Kopec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario E. G.","family":"Moral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruna J.","family":"Siahaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,29]]},"reference":[{"key":"8_CR1","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0022-3549(15)00188-4","volume":"105","author":"A Alaofi","year":"2016","unstructured":"Alaofi A, On N, Kiptoo P, Williams TD, Miller DW, Siahaan TJ (2016) Comparison of linear and cyclic His-Ala-Val peptides in modulating the blood-brain barrier permeability: impact on delivery of molecules to the brain. J Pharm Sci 105:797\u2013807","journal-title":"J Pharm Sci"},{"key":"8_CR2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/07391102.2015.1133321","volume":"35","author":"A Alaofi","year":"2017","unstructured":"Alaofi A, Farokhi E, Prasasty VD, Anbanandam A, Kuczera K, Siahaan TJ (2017) Probing the interaction between cHAVc3 peptide and the EC1 domain of E-cadherin using NMR and molecular dynamics simulations. J Biomol Struct Dyn 35:92\u2013104","journal-title":"J Biomol Struct Dyn"},{"key":"8_CR3","doi-asserted-by":"crossref","first-page":"a002584","DOI":"10.1101\/cshperspect.a002584","volume":"1","author":"JM Anderson","year":"2009","unstructured":"Anderson JM, Van Itallie CM (2009) Physiology and function of the tight junction. Cold Spring Harb Perspect Biol 1:a002584","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"8_CR4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1126\/science.279.5349.377","volume":"279","author":"W Arap","year":"1998","unstructured":"Arap W, Pasqualini R, Ruoslahti E (1998) Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279:377\u2013380","journal-title":"Science"},{"key":"8_CR5","doi-asserted-by":"crossref","first-page":"6318","DOI":"10.1073\/pnas.86.16.6318","volume":"86","author":"S Bajusz","year":"1989","unstructured":"Bajusz S, Janaky T, Csernus VJ, Bokser L, Fekete M, Srkalovic G, Redding TW, Schally AV (1989) Highly potent analogues of luteinizing hormone-releasing hormone containing D-phenylalanine nitrogen mustard in position 6. Proc Natl Acad Sci U S A 86:6318\u20136322","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8_CR6","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1016\/j.nano.2016.07.007","volume":"12","author":"A Barve","year":"2016","unstructured":"Barve A, Jain A, Liu H, Jin W, Cheng K (2016) An enzyme-responsive conjugate improves the delivery of a PI3K inhibitor to prostate cancer. Nanomedicine 12:2373\u20132381","journal-title":"Nanomedicine"},{"key":"8_CR7","doi-asserted-by":"crossref","unstructured":"Beer AJ, Haubner R, Sarbia M, Goebel M, Luderschmidt S, Grosu AL, Schnell O, Niemeyer M, Kessler H, Wester HJ, Weber WA, Schwaiger M (2006) Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin \u03b1V\u03b23 expression in man. Clin Cancer Res 12:3942\u20133949","DOI":"10.1158\/1078-0432.CCR-06-0266"},{"key":"8_CR8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/jmwh.12101","volume":"59","author":"AF Bell","year":"2014","unstructured":"Bell AF, Erickson EN, Carter CS (2014) Beyond labor: the role of natural and synthetic oxytocin in the transition to motherhood. J Midwifery Womens Health 59:35\u201342","journal-title":"J Midwifery Womens Health"},{"key":"8_CR9","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.xphs.2015.11.018","volume":"105","author":"A Bocsik","year":"2016","unstructured":"Bocsik A, Walter FR, Gyebrovszki A, F\u00fcl\u00f6p L, Blasig I, Dabrowski S, \u00d6tv\u00f6s F, T\u00f3th A, R\u00e1khely G, Veszelka S, Vastag M, Szab\u00f3-R\u00e9v\u00e9sz P, Deli MA (2016) Reversible opening of intercellular junctions of intestinal epithelial and brain endothelial cells with tight junction modulator peptides. J Pharm Sci 105:754\u2013765","journal-title":"J Pharm Sci"},{"key":"8_CR10","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.3748\/wjg.v21.i6.1945","volume":"21","author":"MS Broder","year":"2015","unstructured":"Broder MS, Beenhouwer D, Strosberg JR, Neary MP, Cherepanov D (2015) Gastrointestinal neuroendocrine tumors treated with high dose octreotide-LAR: a systematic literature review. World J Gastroenterol 21:1945\u20131955","journal-title":"World J Gastroenterol"},{"key":"8_CR11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1021\/acs.molpharmaceut.6b00847","volume":"14","author":"KE Burns","year":"2017","unstructured":"Burns KE, Hensley H, Robinson MK, Th\u00e9venin D (2017) Therapeutic efficacy of a family of pHLIP-MMAF conjugates in cancer cells and mouse models. Mol Pharm 14:415\u2013422","journal-title":"Mol Pharm"},{"key":"8_CR12","volume-title":"Drug delivery: principles and applications","author":"B B\u00fcy\u00fcktimkin","year":"2016","unstructured":"B\u00fcy\u00fcktimkin B, Stewart Jr J, Tabanor K, Kiptoo P, Siahaan TJ (2016). Protein and peptide conjugates for targeting therapeutics and diagnostics to specific cells. In: Wang B, Hu L, Siahaan TJ (eds) Drug delivery: principles and applications, 2nd. Wiley, Hoboken","edition":"2nd"},{"key":"8_CR13","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1021\/bm060336m","volume":"7","author":"J Callahan","year":"2006","unstructured":"Callahan J, Kopecek J (2006) Semitelechelic HPMA copolymers functionalized with triphenylphosphonium as drug carriers for membrane transduction and mitochondrial localization. Biomacromolecules 7:2347\u20132356","journal-title":"Biomacromolecules"},{"key":"8_CR14","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1021\/jm049165z","volume":"48","author":"X Chen","year":"2005","unstructured":"Chen X, Plasencia C, Hou Y, Neamati N (2005) Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery. J Med Chem 48:1098\u20131106","journal-title":"J Med Chem"},{"key":"8_CR15","doi-asserted-by":"crossref","first-page":"83451","DOI":"10.18632\/oncotarget.13120","volume":"7","author":"X Chen","year":"2016","unstructured":"Chen X, Zhang XY, Shen Y, Fan LL, Ren ML, Wu YP (2016) Synthetic paclitaxel-octreotide conjugate reversing the resistance of A2780\/Taxol to paclitaxel in xenografted tumor in nude mice. Oncotarget 7:83451\u201383461","journal-title":"Oncotarget"},{"key":"8_CR16","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1021\/acs.bioconjchem.5b00481","volume":"27","author":"A Cordova","year":"2016","unstructured":"Cordova A, Woodrick J, Grindrod S, Zhang L, Saygideger-Kont Y, Wang K, DeVito S, Daniele SG, Paige M, Brown ML (2016) Aminopeptidase P mediated targeting for breast tissue specific conjugate delivery. Bioconjug Chem 27:1981\u20131990","journal-title":"Bioconjug Chem"},{"key":"8_CR17","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.bbamem.2008.09.016","volume":"1788","author":"MA Deli","year":"2009","unstructured":"Deli MA (2009) Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery. BBA-Biomembranes 1788:892\u2013910","journal-title":"BBA-Biomembranes"},{"key":"8_CR18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0168-3659(03)00209-8","volume":"91","author":"SS Dharap","year":"2003","unstructured":"Dharap SS, Qiu B, Williams GC, Sinko P, Stein S, Minko T (2003) Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides. J Control Rel 91:61\u201373","journal-title":"J Control Rel"},{"key":"8_CR19","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/jps.20676","volume":"95","author":"AL Dunehoo","year":"2006","unstructured":"Dunehoo AL, Anderson M, Majumdar S, Kobayashi N, Berkland C, Siahaan TJ (2006) Cell adhesion molecules for targeted drug delivery. J Pharm Sci 95:1856\u20131872","journal-title":"J Pharm Sci"},{"key":"8_CR20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","volume":"20","author":"K Fosgerau","year":"2015","unstructured":"Fosgerau K, Hoffmann T (2015) Peptide therapeutics: current status and future directions. Drug Discov Today 20:122\u2013128","journal-title":"Drug Discov Today"},{"key":"8_CR21","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.bbamem.2007.07.014","volume":"1778","author":"D Garrod","year":"2008","unstructured":"Garrod D, Chidgey M (2008) Desmosome structure, composition and function. Biochim Biophys Acta 1778:572\u2013587","journal-title":"Biochim Biophys Acta"},{"key":"8_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0079-6107(02)00037-8","volume":"81","author":"L Gonzalez-Mariscal","year":"2003","unstructured":"Gonzalez-Mariscal L, Betanzos A, Nava P, Jaramillo BE (2003) Tight junction proteins. Prog Biophys Mol Biol 81:1\u201344","journal-title":"Prog Biophys Mol Biol"},{"key":"8_CR23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1021\/bc0100206","volume":"13","author":"PR Hamann","year":"2002","unstructured":"Hamann PR, Hinman LM, Beyer CF, Lindh D, Upeslacis J, Flowers DA, Bernstein I (2002) An anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. Choice of linker. Bioconjug Chem 13:40\u201346","journal-title":"Bioconjug Chem"},{"key":"8_CR24","doi-asserted-by":"crossref","unstructured":"Haubner R, Weber WA, Beer AJ, Vabuliene E, Reim D, Sarbia M, Becker KF, Goebel M, Hein R, Wester HJ, Kessler H, Schwaiger M (2005) Noninvasive visualization of the activated \u03b1V\u03b23 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD. PLoS Med 2:e70","DOI":"10.1371\/journal.pmed.0020070"},{"key":"8_CR25","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/annonc\/mdf142","volume":"13","author":"M Hejna","year":"2002","unstructured":"Hejna M, Schmidinger M, Raderer M (2002) The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing? Ann Oncol 13:653\u2013668","journal-title":"Ann Oncol"},{"key":"8_CR26","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1177\/1087057107310216","volume":"12","author":"RE Herman","year":"2007","unstructured":"Herman RE, Makienko EG, Prieve MG, Fuller M, Houston ME Jr, Johnson PH (2007) Phage display screening of epithelial cell monolayers treated with EGTA: identification of peptide FDFWITP that modulates tight junction activity. J Biomol Screen 12:1092\u20131101","journal-title":"J Biomol Screen"},{"key":"8_CR27","doi-asserted-by":"crossref","first-page":"52230","DOI":"10.18632\/oncotarget.10735","volume":"7","author":"C Huang","year":"2016","unstructured":"Huang C, Yi X, Kong D, Chen L, Min G (2016) Controlled release strategy of paclitaxel by conjugating to matrix metalloproteinases-2 sensitive peptide. Oncotarget 7:52230\u201352238","journal-title":"Oncotarget"},{"key":"8_CR28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0168-3659(02)00352-8","volume":"87","author":"KD Jensen","year":"2003","unstructured":"Jensen KD, Nori A, Tijerina M, Kopeckov\u00e1 P, Kopecek J (2003) Cytoplasmic delivery and nuclear targeting of synthetic macromolecules. J Control Release 87:89\u2013105","journal-title":"J Control Release"},{"key":"8_CR29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1021\/acsami.6b13805","volume":"9","author":"Y Jiang","year":"2017","unstructured":"Jiang Y, Wang X, Liu X, Lv W, Zhang H, Zhang M, Li X, Xin H, Xu Q (2017) Enhanced antiglioma efficacy of ultrahigh loading capacity paclitaxel prodrug conjugate self-assembled targeted nanoparticles. ACS Appl Mater Interfaces 9:211\u2013217","journal-title":"ACS Appl Mater Interfaces"},{"key":"8_CR30","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2796.2010.02268.x","volume":"268","author":"DP Jones","year":"2010","unstructured":"Jones DP (2010) Redox sensing: orthogonal control in cell cycle and apoptosis signalling. J Internal Med 268:432\u2013448","journal-title":"J Internal Med"},{"key":"8_CR31","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1021\/ja9102698","volume":"132","author":"B Kang","year":"2010","unstructured":"Kang B, Mackey MA, El-Sayed MA (2010) Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis. J Am Chem Soc 132:1517\u20131519","journal-title":"J Am Chem Soc"},{"key":"8_CR32","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.drudis.2013.05.011","volume":"18","author":"AA Kaspar","year":"2013","unstructured":"Kaspar AA, Reichert JM (2013) Future directions for peptide therapeutics development. Drug Discov Today 18:807\u2013817","journal-title":"Drug Discov Today"},{"key":"8_CR33","doi-asserted-by":"crossref","first-page":"34297","DOI":"10.1038\/srep34297","volume":"6","author":"JA Kim","year":"2016","unstructured":"Kim JA, Casalini T, Brambilla D, Leroux JC (2016) Presumed LRP1-targeting transport peptide delivers beta-secretase inhibitor to neurons in vitro with limited efficiency. Sci Rep 6:34297","journal-title":"Sci Rep"},{"key":"8_CR34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1021\/mp100293m","volume":"8","author":"P Kiptoo","year":"2011","unstructured":"Kiptoo P, Sinaga E, Calcagno AM, Zhao H, Kobayashi N, Tambunan US, Siahaan TJ (2011) Enhancement of drug absorption through the blood-brain barrier and inhibition of intercellular tight junction resealing by E-cadherin peptides. Mol Pharm 8:239\u2013249","journal-title":"Mol Pharm"},{"key":"8_CR35","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/14656566.2017.1282463","volume":"18","author":"FK Knop","year":"2017","unstructured":"Knop FK, Bronden A, Vilsboll T (2017) Exenatide: pharmacokinetics, clinical use, and future directions. Expert Opin Pharmacother 18:555\u2013571","journal-title":"Expert Opin Pharmacother"},{"key":"8_CR36","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.4155\/tde.14.67","volume":"5","author":"M Laksitorini","year":"2014","unstructured":"Laksitorini M, Prasasty VD, Kiptoo PK, Siahaan TJ (2014) Pathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriers. Ther Deliv 5:1143\u20131163","journal-title":"Ther Deliv"},{"key":"8_CR37","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/jps.24309","volume":"104","author":"MD Laksitorini","year":"2015","unstructured":"Laksitorini MD, Kiptoo PK, On NH, Thliveris JA, Miller DW, Siahaan TJ (2015) Modulation of intercellular junctions by cyclic-ADT peptides as a method to reversibly increase blood-brain barrier permeability. J Pharm Sci 104:1065\u20131075","journal-title":"J Pharm Sci"},{"key":"8_CR38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/nyas.12499","volume":"1321","author":"M Leal","year":"2014","unstructured":"Leal M, Sapra P, Hurvitz SA, Senter P, Wahl A, Schutten M, Shah DK, Haddish-Berhane N, Kabbarah O (2014) Antibody-drug conjugates: an emerging modality for the treatment of cancer. Annals NY Acad Sci 1321:41\u201354","journal-title":"Annals NY Acad Sci"},{"key":"8_CR39","doi-asserted-by":"crossref","first-page":"79401","DOI":"10.18632\/oncotarget.12708","volume":"7","author":"Y Li","year":"2016","unstructured":"Li Y, Zheng X, Gong M, Zhang J (2016) Delivery of a peptide-drug conjugate targeting the blood brain barrier improved the efficacy of paclitaxel against glioma. Oncotarget 7:79401\u201379407","journal-title":"Oncotarget"},{"key":"8_CR40","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.yfrne.2003.10.003","volume":"24","author":"P Limonta","year":"2003","unstructured":"Limonta P, Montagnani MM, Marelli M, Motta M (2003) The biology of gonadotropin hormone-releasing hormone: role in the control of tumor growth and progression in humans. Front Neuroendocrinol 24:279\u2013295","journal-title":"Front Neuroendocrinol"},{"key":"8_CR41","doi-asserted-by":"crossref","first-page":"33148","DOI":"10.1021\/acsami.6b09333","volume":"8","author":"N Liu","year":"2016","unstructured":"Liu N, Tan Y, Hu Y, Meng T, Wen L, Liu J, Cheng B, Yuan H, Huang X, Hu F (2016) A54 peptide modified and redox-responsive glucolipid conjugate micelles for intracellular delivery of doxorubicin in hepatocarcinoma therapy. ACS Appl Mater Interfaces 8:33148\u201333156","journal-title":"ACS Appl Mater Interfaces"},{"key":"8_CR42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/10717549709051891","volume":"4","author":"KL Lutz","year":"1997","unstructured":"Lutz KL, Siahaan TJ (1997a) Modulation of the cellular junction protein E-cadherin in bovine brain microvessel endothelial cells by cadherin peptides. Drug Deliv 4:187\u2013193","journal-title":"Drug Deliv"},{"key":"8_CR43","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1021\/js970134j","volume":"86","author":"KL Lutz","year":"1997","unstructured":"Lutz KL, Siahaan TJ (1997b) Molecular structure of the apical junction complex and its contribution to the paracellular barrier. J Pharm Sci 86:977\u2013984","journal-title":"J Pharm Sci"},{"key":"8_CR44","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/med.20225","volume":"32","author":"S Majumdar","year":"2012","unstructured":"Majumdar S, Siahaan TJ (2012) Peptide-mediated targeted drug delivery. Med Res Rev 32:637\u2013658","journal-title":"Med Res Rev"},{"key":"8_CR45","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2741\/e772","volume":"8","author":"D Majumdar","year":"2016","unstructured":"Majumdar D, Rahman MA, Chen ZG, Shin DM (2016) Anticancer activity of drug conjugates in head and neck cancer cells. Front Biosci 8:358\u2013369","journal-title":"Front Biosci"},{"key":"8_CR46","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1023\/A:1011094025008","volume":"18","author":"IT Makagiansar","year":"2001","unstructured":"Makagiansar IT, Avery M, Hu Y, Audus KL, Siahaan TJ (2001) Improving the selectivity of HAV-peptides in modulating E-cadherin-E-cadherin interactions in the intercellular junction of MDCK cell monolayers. Pharm Res 18:446\u2013453","journal-title":"Pharm Res"},{"key":"8_CR47","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2174\/187152010794728639","volume":"10","author":"C Mas-Moruno","year":"2010","unstructured":"Mas-Moruno C, Rechenmacher F, Kessler H (2010) Cilengitide: the first anti-angiogenic small molecule drug candidate design, synthesis and clinical evaluation. Anti Cancer Agents Med Chem 10:753\u2013768","journal-title":"Anti Cancer Agents Med Chem"},{"key":"8_CR48","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev.nutr.25.050304.092633","volume":"25","author":"AJ McEligot","year":"2005","unstructured":"McEligot AJ, Yang S, Meyskens FL Jr (2005) Redox regulation by intrinsic species and extrinsic nutrients in normal and cancer cells. Ann Rev Nutr 25:261\u2013295","journal-title":"Ann Rev Nutr"},{"key":"8_CR49","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/psc.2904","volume":"22","author":"J Mur\u00e1nyi","year":"2016","unstructured":"Mur\u00e1nyi J, Gyulav\u00e1ri P, Varga A, B\u00f6k\u00f6nyi G, Tanai H, V\u00e1ntus T, Pap D, Lud\u00e1nyi K, Mez\u0151 G, K\u00e9ri G (2016) Synthesis, characterization and systematic comparison of FITC-labelled GnRH-I, \u2212II and -III analogues on various tumour cells. J Pept Sci 22:552\u2013560","journal-title":"J Pept Sci"},{"key":"8_CR50","doi-asserted-by":"crossref","first-page":"7269","DOI":"10.1073\/pnas.93.14.7269","volume":"93","author":"A Nagy","year":"1996","unstructured":"Nagy A, Schally AV, Armatis P, Szepeshazi K, Halmos G, Kovacs M, Zarandi M, Groot K, Miyazaki M, Jungwirth A, Horvath J (1996) Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500\u20131000 times more potent. Proc Natl Acad Sci U S A 93:7269\u20137273","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8_CR51","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1172\/JCI109509","volume":"64","author":"EA Neuwelt","year":"1979","unstructured":"Neuwelt EA, Maravilla KR, Frenkel EP, Rapaport SI, Hill SA, Barnett PA (1979) Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery. J Clin Invest 64:684\u2013688","journal-title":"J Clin Invest"},{"key":"8_CR52","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1227\/00006123-198409000-00011","volume":"15","author":"EA Neuwelt","year":"1984","unstructured":"Neuwelt EA, Hill SA, Frenkel EP (1984) Osmotic blood-brain barrier modification and combination chemotherapy: concurrent tumor regression in areas of barrier opening and progression in brain regions distant to barrier opening. Neurosurgery 15:362\u2013366","journal-title":"Neurosurgery"},{"key":"8_CR53","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1227\/00006123-198706000-00011","volume":"20","author":"EA Neuwelt","year":"1987","unstructured":"Neuwelt EA, Specht HD, Barnett PA, Dahlborg SA, Miley A, Larson SM, Brown P, Eckerman KF, Hellstr\u00f6m KE, Hellstr\u00f6m I (1987) Increased delivery of tumor-specific monoclonal antibodies to brain after osmotic blood-brain barrier modification in patients with melanoma metastatic to the central nervous system. Neurosurgery 20:885\u2013895","journal-title":"Neurosurgery"},{"key":"8_CR54","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/jeb.106.1.231","volume":"106","author":"MJ O\u2019Donnell","year":"1983","unstructured":"O\u2019Donnell MJ, Maddrell SH (1983) Paracellular and transcellular routes for water and solute movements across insect epithelia. J Exp Biol 106:231\u2013253","journal-title":"J Exp Biol"},{"key":"8_CR55","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1021\/mp400624v","volume":"11","author":"NH On","year":"2014","unstructured":"On NH, Kiptoo P, Siahaan TJ, Miller DW et al (2014) Modulation of blood-brain barrier permeability in mice using synthetic E-cadherin peptide. Mol Pharm 11:974\u2013981","journal-title":"Mol Pharm"},{"key":"8_CR56","first-page":"263","volume":"85","author":"M P\u00e1ez Pereda","year":"2000","unstructured":"P\u00e1ez Pereda M, Ledda MF, Goldberg V, Cherv\u00edn A, Carrizo G, Molina H, M\u00fcller A, Renner U, Podhajcer O, Arzt E, Stalla GK (2000) High levels of matrix metalloproteinases regulate proliferation and hormone secretion in pituitary cells. J Clin Endocrin Metab 85:263\u2013269","journal-title":"J Clin Endocrin Metab"},{"key":"8_CR57","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0006-8993(96)01223-1","volume":"747","author":"D Pal","year":"1997","unstructured":"Pal D, Audus KL, Siahaan TJ (1997) Modulation of cellular adhesion in bovine brain microvessel endothelial cells by a decapeptide. Brain Res 747:103\u2013113","journal-title":"Brain Res"},{"key":"8_CR58","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","volume":"32","author":"WM Pardridge","year":"2012","unstructured":"Pardridge WM (2012) Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab 32:1959\u20131972","journal-title":"J Cereb Blood Flow Metab"},{"key":"8_CR59","doi-asserted-by":"crossref","first-page":"757","DOI":"10.18632\/oncotarget.12748","volume":"8","author":"B Redko","year":"2016","unstructured":"Redko B, Tuchinsky H, Segal T, Tobi D, Luboshits G, Ashur-Fabian O, Pinhasov A, Gerlitz G, Gellerman G (2016) Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma. Oncotarget 8:757\u2013768","journal-title":"Oncotarget"},{"key":"8_CR60","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/bjp.2008.260","volume":"155","author":"A Regina","year":"2008","unstructured":"Regina A, Demeule M, Ch\u00e9 C, Lavall\u00e9e I, Poirier J, Gabathuler R, B\u00e9liveau R, Castaigne JP (2008) Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2. Br J Pharmacol 155:185\u2013197","journal-title":"Br J Pharmacol"},{"key":"8_CR61","first-page":"99","volume":"24","author":"E Ruoslahti","year":"1994","unstructured":"Ruoslahti E (1994) Cell adhesion and tumor metastasis. Princess Takamatsu Symp 24:99\u2013105","journal-title":"Princess Takamatsu Symp"},{"key":"8_CR62","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1126\/science.2821619","volume":"238","author":"E Ruoslahti","year":"1987","unstructured":"Ruoslahti E, Pierschbacher MD (1987) New perspectives in cell adhesion: RGD and integrins. Science 238:491\u2013497","journal-title":"Science"},{"key":"8_CR63","doi-asserted-by":"crossref","first-page":"C1213","DOI":"10.1152\/ajpcell.00558.2003","volume":"286","author":"EE Schneeberger","year":"2004","unstructured":"Schneeberger EE, Lynch RD (2004) The tight junction: a multifunctional complex. Am J Physiol Cell Physiol 286:C1213\u2013C1228","journal-title":"Am J Physiol Cell Physiol"},{"key":"8_CR64","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1021\/mp500386y","volume":"12","author":"Y Sheng","year":"2015","unstructured":"Sheng Y, Xu J, You Y, Xu F, Chen Y (2015) Acid-sensitive peptide-conjugated doxorubicin mediates the lysosomal pathway of apoptosis and reverses drug resistance in breast cancer. Mol Pharm 12:2217\u20132228","journal-title":"Mol Pharm"},{"key":"8_CR65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2016.08.016","volume":"512","author":"Y Sheng","year":"2016","unstructured":"Sheng Y, You Y, Chen Y (2016) Dual-targeting hybrid peptide-conjugated doxorubicin for drug resistance reversal in breast cancer. Int J Pharm 512:1\u201313","journal-title":"Int J Pharm"},{"key":"8_CR66","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1023\/A:1019850226631","volume":"19","author":"E Sinaga","year":"2002","unstructured":"Sinaga E, Jois SD, Avery M, Makagiansar IT, Tambunan US, Audus KL, Siahaan TJ (2002) Increasing paracellular porosity by E-cadherin peptides: discovery of bulge and groove regions in the EC1-domain of E-cadherin. Pharm Res 19:1170\u20131179","journal-title":"Pharm Res"},{"key":"8_CR67","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1073\/pnas.0931245100","volume":"100","author":"RAJ Smith","year":"2003","unstructured":"Smith RAJ, Porteous CM, Gane AM, Murphy MP (2003) Delivery of bioactive molecules to mitochondria in vivo. Proc Natl Acad Sci U S A 100:5407\u20135412","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8_CR68","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.colsurfb.2015.09.030","volume":"136","author":"H Song","year":"2015","unstructured":"Song H, Zhang J, Wang W, Huang P, Zhang Y, Liu J, Li C, Kong D (2015) Acid-responsive PEGylated doxorubicin prodrug nanoparticles for neuropilin-1 receptor-mediated targeted drug delivery. Colloids Surf B Biointerfaces 136:365\u2013374","journal-title":"Colloids Surf B Biointerfaces"},{"key":"8_CR69","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1083\/jcb.147.1.195","volume":"147","author":"N Sonoda","year":"1999","unstructured":"Sonoda N, Furuse M, Sasaki H, Yonemura S, Katahira J, Horiguchi Y, Tsukita S (1999) Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: evidence for direct involvement of claudins in tight junction barrier. J Cell Biol 147:195\u2013204","journal-title":"J Cell Biol"},{"key":"8_CR70","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.biomaterials.2015.03.007","volume":"54","author":"C Staat","year":"2015","unstructured":"Staat C, Coisne C, Dabrowski S, Stamatovic SM, Andjelkovic AV, Wolburg H, Engelhardt B, Blasig IE (2015) Mode of action of claudin peptidomimetics in the transient opening of cellular tight junction barriers. Biomaterials 54:9\u201320","journal-title":"Biomaterials"},{"key":"8_CR71","doi-asserted-by":"crossref","unstructured":"Sun W, Li L, Yang QQ, Zhang ZR, Huang Y (2017) Two birds, one stone: dual targeting of the cancer cell surface and subcellular mitochondria by the galectin-3-binding peptide G3-C12. Acta Pharmacol Sin:1\u201317","DOI":"10.1038\/aps.2016.137"},{"key":"8_CR72","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1124\/mol.64.6.1530","volume":"64","author":"S Tavelin","year":"2003","unstructured":"Tavelin S, Hashimoto K, Malkinson J, Lazorova L, Toth I, Artursson P (2003) A new principle for tight junction modulation based on occludin peptides. Mol Pharmacol 64:1530\u20131540","journal-title":"Mol Pharmacol"},{"key":"8_CR73","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jsbmb.2013.09.008","volume":"142","author":"SH Tella","year":"2014","unstructured":"Tella SH, Gallagher JC (2014) Prevention and treatment of postmenopausal osteoporosis. J Steroid Biochem Mol Biol 142:155\u2013170","journal-title":"J Steroid Biochem Mol Biol"},{"key":"8_CR74","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1007\/s11095-009-9964-5","volume":"26","author":"FC Thomas","year":"2009","unstructured":"Thomas FC, Taskar K, Rudraraju V, Goda S, Thorsheim HR, Gaasch JA, Mittapalli RK, Palmieri D, Steeg PS, Lockman PR, Smith QR (2009) Uptake of ANG1005, a novel paclitaxel derivative, through the blood-brain barrier into brain and experimental brain metastases of breast cancer. Pharm Res 26:2486\u20132494","journal-title":"Pharm Res"},{"key":"8_CR75","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.euprot.2014.05.003","volume":"4","author":"T Uhlig","year":"2014","unstructured":"Uhlig T, Kyprianou T, Martinelli FG, Oppici CA, Heiligers D, Hills D, Calvo XR, Verhaert P (2014) The emergence of peptides in the pharmaceutical business: from exploration to exploitation. EuPA Open Proteom 4:58\u201369","journal-title":"EuPA Open Proteom"},{"key":"8_CR84","doi-asserted-by":"crossref","unstructured":"Ulapane KR, On N, Kiptoo P, Williams TD, Miller DW, Siahaan TJ (2017) Improving brain delivery of biomolecules via BBB modulation in mouse and rat: Detection using MRI, NIRF, and mass spectrometry. Nanotheranostics 1:217\u2013231","DOI":"10.7150\/ntno.19158"},{"key":"8_CR77","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.semcdb.2014.08.011","volume":"36","author":"CM Itallie Van","year":"2014","unstructured":"Van Itallie CM, Anderson JM (2014) Architecture of tight junctions and principles of molecular composition. Semin Cell Dev Biol 36:157\u2013165","journal-title":"Semin Cell Dev Biol"},{"key":"8_CR78","doi-asserted-by":"crossref","first-page":"1600292","DOI":"10.1002\/mabi.201600292","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Wang L, Chen G, Gong S (2016) Carboplatin-complexed and cRGD-conjugated unimolecular nanoparticles for targeted ovarian cancer therapy. Macromol Biosci 17:1600292","journal-title":"Macromol Biosci"},{"key":"8_CR79","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1083\/jcb.136.2.399","volume":"136","author":"V Wong","year":"1997","unstructured":"Wong V, Gumbiner BM (1997) A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J Cell Biol 136:399\u2013409","journal-title":"J Cell Biol"},{"key":"8_CR80","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.colsurfb.2015.10.004","volume":"136","author":"X Xie","year":"2015","unstructured":"Xie X, Yang Y, Lin W, Liu H, Liu H, Yang Y, Chen Y, Fu X, Deng J (2015) Cell-penetrating peptide-siRNA conjugate loaded YSA-modified nanobubbles for ultrasound triggered siRNA delivery. Colloids Surf B Biointerf 136:641\u2013650","journal-title":"Colloids Surf B Biointerf"},{"key":"8_CR81","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/med.10001","volume":"22","author":"H Yusuf-Makagiansar","year":"2002","unstructured":"Yusuf-Makagiansar H, Anderson ME, Yakovleva TV, Murray JS, Siahaan TJ (2002) Inhibition of LFA-1\/ICAM-1 and VLA-4\/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases. Med Res Rev 22:146\u2013167","journal-title":"Med Res Rev"},{"key":"8_CR82","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.2174\/138161206777947722","volume":"12","author":"K Zheng","year":"2006","unstructured":"Zheng K, Trivedi M, Siahaan TJ (2006) Structure and function of the intercellular junctions: barrier of paracellular drug delivery. Curr Pharm Des 12:2813\u20132824","journal-title":"Curr Pharm Des"},{"key":"8_CR83","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1021\/mp3000937","volume":"9","author":"D Zwanziger","year":"2012","unstructured":"Zwanziger D, Hackel D, Staat C, B\u00f6cker A, Brack A, Beyermann M, Rittner H, Blasig IE (2012) A peptidomimetic tight junction modulator to improve regional analgesia. Mol Pharm 9:1785\u20131794","journal-title":"Mol Pharm"}],"container-title":["Advances in Experimental Medicine and Biology","Peptides and Peptide-based Biomaterials and their Biomedical Applications"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-66095-0_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T15:33:49Z","timestamp":1659713629000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-66095-0_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783319660943","9783319660950"],"references-count":83,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-66095-0_8","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}